EIT-URBAN-MOBILITY
16.11.2021 09:02:12 CET | Business Wire | Press release
Tomorrow.Mobility World Congress (TMWC) is a new global event, co-organised by Fira de Barcelona and EIT Urban Mobility, focused on promoting the design and adoption of new sustainable urban mobility models. TMWC is being launched to create a global benchmark in the field of mobility and to go beyond a one-off event, as it will include an online knowledge platform that will be active throughout the year and an innovation hub set to bring the main players in the industry together.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211116005046/en/
EIT Urban Mobility is the largest European initiative for the transformation of urban mobility, created by the European Institute of Innovation and Technology (EIT), a body of the European Union. This European initiative benefits of the strategic partnership with Fira de Barcelona by increasing the impact of its European partnership and jointly reaching to a wider audience globally in the mobility scene. Tomorrow.Mobility represents EIT Urban Mobility’s flagship event 2021, showcasing its most promising innovation projects, results, demonstrations, and supported start-ups.
TMWC will bring insights from the global mobility ecosystem gathered under one roof. Being aware of the strong ties that mobility has with other sectors, the event is co-located with Smart City Expo World Congress (SCEWC). More than 350 speakers will be joining alongside hundreds of exhibitors and thousands of attendees. Twelve inspiring congress sessions featuring high-level speakers from both the public and private sector will take place under the umbrella of Tomorrow.Mobility. Speakers include Maria Tsavachidis, CEO of EIT Urban Mobility & President of the Board of Tomorrow.Mobility; Matthew Baldwin, Deputy Director-General for DG MOVE, European Commission; Mark Major, Senior Advisor to the Partnership on Sustainable, Low Carbon Transport (SLoCaT); Carlos Moreno, Scientific director of the Chair Entrepreneurship Territory Innovation, University Panthéon Sorbonne – IAE Paris; and Anna Lisa Boni, Secretary General at Eurocities.
Dr. Maria Tsavachidis, CEO of EIT Urban Mobility & President of the Advisory Board of TMWC stated that “our collaboration with Fira de Barcelona will help expand the network of innovation for urban mobility in Europe and beyond. Our goal is to foster innovation and transformation towards sustainable mobility, to decarbonise mobility, improve people’s quality of life, and make Europe’s economy more competitive. Bringing together the world´s leaders and frontrunners in sustainable mobility under the umbrella of Tomorrow.Mobility is an important steppingstone towards this goal. It will inspire and create new opportunities for our partners, cities, startups, and their innovations ”.
Numerous start-ups supported by EIT Urban Mobility will be showcasing their high-tech solutions at their booths and demo areas, such as: Bia Power (Autonomous Vehicles/Spain), BlockCity (Mobility Services/Hungary), Dashfactory Gmbh (Sensors & Training Data/Germany), Delivers.ai (Last Mile Delivery/Turkey), Vianova (Sensors Data/France), and SmartMonkey (Green Logistics/Spain).
Several EIT Urban Mobility supported innovation projects will be featured at the Central Agora during two different sessions. One session focusing on managing shared public space, and another on how to put Mobility as a Service (MaaS) solutions into practice. Among the EIT Urban Mobility supported projects presented are, FURNISH , which promotes the redesign of public spaces to prevent the spread of COVID-19. Another notable project is HALLO, which creates shared urban consolidation and distribution centres through a series of pilots in Barcelona and Stockholm.
Tomorrow.Mobility, held with the Smart City Expo World Congress (SCEWC), a leading tradeshow & congress on smart cities, has the initial support of over a hundred global companies and trusted institutions amongst which feature the World Bank, the World Economic Forum, the United Nations, Microsoft, Mastercard, ADP (Airports of Paris), the International Association of Ports and Harbours, the Port of Barcelona, Moventia, the RACC and Social Car. The event seeks to tackle the future challenges facing mobility, an industry that will be one of the main drivers of future growth, with a market volume of 60,000 million euros in 2027.
The new event, which will include a congress and exhibition area, will hold a first pilot edition in November and again in 2022. It will address current mobility challenge areas such as micromobility (electric scooters, bicycles), active mobility and the public realm, public transport, mobility providers (car sharing, air taxis), the car industry (electric, connected, and autonomous cars), last mile logistics (e-commerce deliveries, delivery drones), smart infrastructures (fleet management, geolocation, and payment systems), the energy transition towards carbon neutrality and digitisation.
The objective of Tomorrow.Mobility is to go beyond being just an event. The launch of the new show will be accompanied by the creation of a digital content platform with a global reach operating 365 days a year, turning it into the go-to global stage for urban, sustainable, and smart mobility. This platform will allow access to both live events and à la carte contents divided into themes with the aim of facilitating knowledge transfer, training & network.
Practical information
- Dates: 16, 17 & 18 November 2021
- Opening hours: Tue & Wed: 9.00-19.00 CET | Thu: 9.00-17.00 CET
-
Location:
Fira de Barcelona Gran Via – Halls 1 & 2 -
Av. Joan Carles I, 64 - 08908 L’Hospitalet de Llobregat, Barcelona, Spain - EIT Urban Mobility Booth @ Tomorrow.Mobility: Street D, Stand 174
- Event website: www.tomorrowmobility.com
BACKGROUND
About EIT Urban Mobility
EIT Urban Mobility, an initiative of the European Institute of Innovation and Technology (EIT)
, a body of the European Union, aims to accelerate solutions and the transition towards a user-centric, integrated and truly multimodal transport system. As the leading European innovation community for urban mobility, EIT Urban Mobility works to avoid fragmentation by facilitating collaboration between cities, industry, academia, research and innovation to solve the most pressing mobility challenges of cities. Using cities as living labs, its industry, research and university partners will demonstrate how new technologies can work to solve real problems in real cities by transporting people, goods and waste in smarter ways.
For more information visit www.eiturbanmobility.eu .
Follow EIT Urban Mobility on: Linkedin Twitter Facebook Youtube Instagram
View source version on businesswire.com: https://www.businesswire.com/news/home/20211116005046/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 10:16:00 CEST | Press release
The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav
New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk28.8.2026 10:00:00 CEST | Press release
Analyses from the multinational MILOS study show that LDL-C reductions achieved with up to one year of treatment with bempedoic acid-containing therapies translate to a 17.1% relative reduction and a 4.8% absolute reduction in predicted 10-year cardiovascular risk.1 Real-world data demonstrated clinically relevant mean LDL-C reductions of at least 24.9%, regardless of patient gender or glycaemic status, after one year of follow-up.2,3 Findings presented at ESC Congress 2026 reinforce the clinical value of bempedoic acid in routine clinical practice, and demonstrate the continued investment of Daiichi Sankyo in addressing outstanding unmet needs in cardiovascular disease (CVD). Daiichi Sankyo (TSE:4568) today announced new results from the MILOS study that demonstrate the real-world impact of bempedoic acid administered either alone or as a fixed-dose combination with ezetimibe, in the management of dyslipidaemia. Presented at the European Society of Cardiology Congress 2026 in Munich,
TVS Motor Company Appoints Peyman Kargar as Director and Chief Executive Officer28.8.2026 09:31:00 CEST | Press release
Peyman Kargar appointed Director and Chief Executive Officer of TVS Motor Company, effective January 27, 2027 K. N. Radhakrishnan to continue as Director and Chief Executive Officer until then and subsequently will serve as Non-Executive Director up to the date of the ensuing AGM scheduled in July 2027 Appointment supports TVS Motor Company's next phase of growth and innovation TVS Motor Company, part of TVS VENU and a leading global manufacturer of two and three-wheelers, today announced the appointment of Peyman Kargar as Director and Chief Executive Officer, effective January 27, 2027. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260827012301/en/ Peyman Kargar Peyman will succeed K. N. Radhakrishnan, who will continue in his role until then to ensure a seamless transition. Following the transition, Radhakrishnan will serve as Non-Executive Director up to the date of the ensuing AGM scheduled in July 2027. He has been a
Philips and Imricor Launch Cardiac Interventional MR Lab Solution, Expanding Longstanding Collaboration27.8.2026 21:27:00 CEST | Press release
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Imricor Medical Systems (ASX: IMR), a pioneer and world-leading developer of MR-compatible products for interventional MR procedures, today announced a new Interventional MR (iMR) lab solution for Philips 1.5T MR. The first commercially available configuration* combines Philips’ 1.5T MRI platform and Imricor's portfolio of iMR systems and consumables, enabling an MR-guided workflow for cardiac intervention, without compromising on MR field strength. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260827693715/en/ Meeting the need for greater tissue insight during cardiac intervention Cardiac arrhythmias affect millions of people worldwide, and catheter ablation is an established and increasingly utilized treatment for many complex cardiac arrhythmias. Yet today, these procedures continue to rely primarily on X-ray fluoroscopy, which provides only
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom